IceCure Medical Ltd (ICCM)

IceCure Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	8.9	7.56	10.53	23.66
Short-Term Investments	-	-	0.53	-
Cash & Short-Term Investments	8.9	7.56	11.06	23.66
Cash Growth	17.62%	-31.62%	-53.24%	-
Accounts Receivable	0.33	0.22	0.1	0.08
Inventory	2.63	1.99	2.28	2.86
Other Current Assets	0.75	0.98	0.74	1.54
Total Current Assets	12.61	10.75	14.18	28.13
Net Property, Plant & Equipment	1.23	1.78	2.19	2.02
Other Long-Term Assets	0.05	0.05	0.03	0.03
Total Assets	13.89	12.58	16.41	30.19
Accounts Payable	0.86	1.23	0.5	0.71
Accrued Expenses	2.66	2.76	3.15	-
Current Portion of Leases	0.2	0.3	0.22	0.17
Other Current Liabilities	1.1	1.23	-	3.46
Total Current Liabilities	4.82	5.51	3.87	4.34
Long-Term Leases	0.01	0.16	0.38	0.43
Total Long-Term Liabilities	0.01	0.16	0.38	0.43
Total Liabilities	4.84	5.68	4.25	4.77
Additional Paid-in Capital	129.49	112.28	102.22	100.83
Retained Earnings	-120.44	-105.38	-90.06	-75.41
Shareholders' Equity	9.05	6.9	12.16	25.42
Total Liabilities & Equity	13.89	12.58	16.41	30.19
Total Debt	0.22	0.46	0.6	0.6
Net Cash (Debt)	8.68	7.11	10.46	23.06
Net Cash Growth	22.17%	-32.09%	-54.63%	-
Net Cash Per Share	0.14	0.14	0.23	0.62
Book Value	9.05	6.9	12.16	25.42
Book Value Per Share	0.14	0.14	0.27	0.69
Tangible Book Value	9.05	6.9	12.16	25.42
Tangible Book Value Per Share	0.14	0.14	0.27	0.69

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q